A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer
Clinical trial NCT01792479 · COMPLETED
Trial details
- NCT number
- NCT01792479
- Sponsor
- BIND Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-04-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.